Markus Ketteler

18.8k total citations · 7 hit papers
242 papers, 13.3k citations indexed

About

Markus Ketteler is a scholar working on Nephrology, Nutrition and Dietetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Markus Ketteler has authored 242 papers receiving a total of 13.3k indexed citations (citations by other indexed papers that have themselves been cited), including 168 papers in Nephrology, 62 papers in Nutrition and Dietetics and 48 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Markus Ketteler's work include Parathyroid Disorders and Treatments (145 papers), Dialysis and Renal Disease Management (56 papers) and Magnesium in Health and Disease (35 papers). Markus Ketteler is often cited by papers focused on Parathyroid Disorders and Treatments (145 papers), Dialysis and Renal Disease Management (56 papers) and Magnesium in Health and Disease (35 papers). Markus Ketteler collaborates with scholars based in Germany, United States and Netherlands. Markus Ketteler's co-authors include Willi Jahnen‐Dechent, Ralf Westenfeld, Vincent Brandenburg, Jürgen Floege, Cora Schäfer, Georg Schlieper, Alexander Heiss, Geoffrey A. Block, Leon J. Schurgers and Sharon M. Moe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

Markus Ketteler

230 papers receiving 13.0k citations

Hit Papers

Magnesium basics 2003 2026 2010 2018 2012 2003 2003 2005 2017 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Magnesium basics
    2012 752 citations Willi Jahnen‐Dechent, Markus Ketteler Clinical Kidney Journal profile →
  2. The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification
    2003 737 citations Cora Schäfer, Alexander Heiss et al. Journal of Clinical Investigation profile →
  3. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study
    2003 736 citations Markus Ketteler, Ralf Westenfeld et al. profile →
  4. IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good, the bad, and the ugly
    2005 734 citations Markus Ketteler et al. Kidney International profile →
  5. Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
    2017 659 citations Markus Ketteler, Geoffrey A. Block et al. Kidney International profile →
  6. Effects of Phosphate Binders in Moderate CKD
    2012 377 citations Geoffrey A. Block, Markus Ketteler et al. profile →
  7. Chronic kidney disease–mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
    2025 24 citations Markus Ketteler, Pieter Evenepoel et al. Kidney International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Ketteler Germany 61 8.5k 3.2k 2.2k 2.1k 1.6k 242 13.3k
Sharon M. Moe United States 59 10.4k 1.2× 3.0k 0.9× 1.9k 0.9× 2.3k 1.1× 2.7k 1.7× 287 14.4k
Geoffrey A. Block United States 50 9.4k 1.1× 3.4k 1.1× 1.9k 0.9× 2.8k 1.3× 2.3k 1.4× 160 14.8k
Tilman B. Drüeke France 67 11.3k 1.3× 3.5k 1.1× 2.5k 1.1× 2.3k 1.1× 2.5k 1.6× 443 18.6k
Masafumi Fukagawa Japan 60 9.2k 1.1× 2.8k 0.9× 2.2k 1.0× 1.7k 0.8× 2.6k 1.6× 519 14.3k
William G. Goodman United States 60 9.7k 1.1× 3.4k 1.1× 2.0k 0.9× 2.0k 0.9× 3.1k 2.0× 185 13.8k
Jürgen Floege Germany 78 12.3k 1.5× 1.9k 0.6× 2.8k 1.3× 3.1k 1.5× 2.4k 1.6× 412 21.0k
Orlando M. Gutiérrez United States 48 6.9k 0.8× 2.5k 0.8× 1.3k 0.6× 1000 0.5× 2.9k 1.8× 203 10.4k
Joachim H. Ix United States 70 7.7k 0.9× 2.3k 0.7× 3.1k 1.4× 3.1k 1.5× 1.9k 1.2× 473 17.7k
Isidro B. Salusky United States 52 7.8k 0.9× 2.2k 0.7× 1.5k 0.7× 1.6k 0.8× 2.6k 1.6× 250 10.9k
Kosaku Nitta Japan 46 7.6k 0.9× 881 0.3× 2.3k 1.1× 2.6k 1.2× 1.4k 0.9× 598 14.8k

Countries citing papers authored by Markus Ketteler

Since Specialization
Citations

This map shows the geographic impact of Markus Ketteler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Ketteler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Ketteler more than expected).

Fields of papers citing papers by Markus Ketteler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Ketteler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Ketteler. The network helps show where Markus Ketteler may publish in the future.

Co-authorship network of co-authors of Markus Ketteler

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Ketteler. A scholar is included among the top collaborators of Markus Ketteler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Ketteler. Markus Ketteler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ketteler, Markus, Pieter Evenepoel, Rachel M. Holden, et al.. (2025). Chronic kidney disease–mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International. 107(3). 405–423. 24 indexed citations breakdown →
2.
Martín-Carro, Beatriz, Juan F. Navarro‐González, Alberto Ortíz, et al.. (2023). Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis. Nephrology Dialysis Transplantation. 38(11). 2589–2597. 5 indexed citations
3.
Komaba, Hirotaka, Markus Ketteler, John Cunningham, & Masafumi Fukagawa. (2021). Old and New Drugs for the Management of Bone Disorders in CKD. Calcified Tissue International. 108(4). 486–495. 12 indexed citations
4.
Vervloet, Marc, Ioannis Boletis, Ángel L.M. de Francisco, et al.. (2020). Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational study. Clinical Kidney Journal. 14(7). 1770–1779. 4 indexed citations
5.
Raggi, Paolo, Antonio Bellasi, David A. Bushinsky, et al.. (2019). Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis. Circulation. 141(9). 728–739. 104 indexed citations
6.
Sprague, Stuart M., Markus Ketteler, Adrian Covic, et al.. (2018). Long‐term efficacy and safety of sucroferric oxyhydroxide in African American dialysis patients. Hemodialysis International. 22(4). 480–491. 12 indexed citations
7.
Ketteler, Markus, Geoffrey A. Block, Pieter Evenepoel, et al.. (2017). Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters. Publisher. 1 indexed citations
8.
Brandenburg, Vincent, Teresa Adragão, Pieter Evenepoel, et al.. (2015). Blueprint for a European calciphylaxis registry initiative: the European Calciphylaxis Network (EuCalNet). Clinical Kidney Journal. 8(5). 567–571. 12 indexed citations
9.
Drechsler, Christiane, Marion Verduijn, Stefan Pilz, et al.. (2011). Bone Alkaline Phosphatase and Mortality in Dialysis Patients. Clinical Journal of the American Society of Nephrology. 6(7). 1752–1759. 84 indexed citations
10.
Cozzolino, Mario, Markus Ketteler, & Daniel Zehnder. (2010). The Vitamin D System: A Crosstalk between the Heart and Kidney. European Journal of Heart Failure. 12(10). 1031–1041. 60 indexed citations
11.
Cranenburg, Ellen C.M., Cees Vermeer, Ralf Koos, et al.. (2008). The Circulating Inactive Form of Matrix Gla Protein (ucMGP) as a Biomarker for Cardiovascular Calcification. Journal of Vascular Research. 45(5). 427–436. 140 indexed citations
12.
Westenfeld, Ralf, Willi Jahnen‐Dechent, & Markus Ketteler. (2007). Vascular Calcification and Fetuin-A Deficiency in Chronic Kidney Disease. Trends in Cardiovascular Medicine. 17(4). 124–128. 60 indexed citations
13.
Westenfeld, Ralf, Christian Schäfer, Ralf Smeets, et al.. (2007). Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Nephrology Dialysis Transplantation. 22(6). 1537–1546. 75 indexed citations
14.
Ketteler, Markus & Cecilia M. Giachelli. (2006). Novel insights into vascular calcification. Kidney International. 70(105). S5–S9. 43 indexed citations
15.
Ketteler, Markus. (2005). Fetuin-A and extraosseous calcification in uremia. Current Opinion in Nephrology & Hypertension. 14(4). 337–342. 52 indexed citations
16.
Brandenburg, Vincent, Ralf Westenfeld, & Markus Ketteler. (2004). The fate of bone after renal transplantation. Journal of Nephrology. 17(2). 190–204. 47 indexed citations
17.
Goodman, William G., Gérard M. London, Kerstin Amann, et al.. (2004). Vascular calcification in chronic kidney disease. American Journal of Kidney Diseases. 43(3). 572–579. 327 indexed citations
18.
Schäfer, Cora, Alexander Heiss, Anke Schwarz, et al.. (2003). The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. Journal of Clinical Investigation. 112(3). 357–366. 737 indexed citations breakdown →
19.
Ketteler, Markus, Ralf Westenfeld, Alexander Gawlik, et al.. (2002). Nitric oxide synthase isoform expression in acute versus chronic anti-Thy 1 nephritis. Kidney International. 61(3). 826–833. 14 indexed citations
20.
Ketteler, Markus, Karl Koch, & Jürgen Floege. (2001). Imaging Techniques in the Diagnosis of Dialysis‐Related Amyloidosis. Seminars in Dialysis. 14(2). 90–93. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sharon M. Moe Breakdown of academic impact, for papers by Geoffrey A. Block Breakdown of academic impact, for papers by Tilman B. Drüeke Breakdown of academic impact, for papers by Masafumi Fukagawa Breakdown of academic impact, for papers by William G. Goodman Breakdown of academic impact, for papers by Jürgen Floege Breakdown of academic impact, for papers by Orlando M. Gutiérrez Breakdown of academic impact, for papers by Joachim H. Ix Breakdown of academic impact, for papers by Isidro B. Salusky Breakdown of academic impact, for papers by Kosaku Nitta
Rankless by CCL
2026